Pharmacological control of asthma.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000336:Aerosols; D001249:Asthma / Q000188:drug therapy* / Q000209:etiology; D001993:Bronchodilator Agents / Q000008:administration & dosage; D002908:Chronic Disease; D004361:Drug Tolerance; D004809:Ephedrine / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008407:Mast Cells / Q000187:drug effects; D010100:Oxygen / Q000097:blood; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D005082:Physical Exertion; D011453:Prostaglandins / Q000627:therapeutic use; D013189:SRS-A / Q000037:antagonists & inhibitors; D013566:Sympathomimetics / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000336:Aerosols; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D010726:Phosphodiesterase Inhibitors; D011453:Prostaglandins; D013189:SRS-A; D013566:Sympathomimetics; D004809:Ephedrine; D007545:Isoproterenol; D000109:Acetylcholine; D010100:Oxygen